Clinical Trial Update: Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating colchicine for prevention of vascular inflammation in non-cardioembolic stroke and transient ischemic attack has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: University College Dublin | Conditions: Ischemic Attack, Transient, Stroke | Phase 3 | Status: COMPLETED